Literature DB >> 77020

Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein.

J H Carson, E Barbarese, P E Braun, T A McPherson.   

Abstract

Components in cerebrospinal fluid that are antigenically related to myelin basic protein have been identified by a technique described recently [Barbarese, E., Braun, P. E. & Carson, J. H. (1977) Proc. Natl. Acad. Sci. USA 74, 3360-3364] involving separating the cerebrospinal fluid proteins by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and measuring the individual components by radioimmunoassay for myelin basic protein. Samples of cerebrospinal fluid from 48 different patients (23 with definite multiple sclerosis, 4 with suspected multiple sclerosis, and 21 with other neurological diseases) were examined by this technique. The results indicate that cerebrospinal fluid can contain at least three separate components that are detected by radioimmunoassay for myelin basic protein. On the basis of their apparent molecular weights, the three components were identified as follows: component I, intact myelin basic protein; component II, proteolytic fragments of myelin basic protein; and component III, a protein of unknown origin with an apparent molecular weight of 50,000. Most samples of cerebrospinal fluid (45 of 48) from patients with multiple sclerosis and from patients with other neurological diseases contained components I and II. Component III was detected in all of the samples from patients with definite multiple sclerosis, in three of four samples from patients with suspected multiple sclerosis, and in none of the samples from patients with other neurological diseases. Some implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77020      PMCID: PMC392465          DOI: 10.1073/pnas.75.4.1976

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  5 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

3.  Identification of prelarge and presmall basic proteins in mouse myelin and their structural relationship to large and small basic proteins.

Authors:  E Barbarese; P E Braun; J H Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

4.  Radioimmunoassay of CSF for encephalitogenic basic protein: a diagnostic test for MS?

Authors:  T A McPherson; A Gilpin; T P Seland
Journal:  Can Med Assoc J       Date:  1972-11-04       Impact factor: 8.262

5.  Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.

Authors:  S R Cohen; R M Herndon; G M McKhann
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

  5 in total
  9 in total

1.  Structural insight into the role of myelin basic protein in multiple sclerosis.

Authors:  Cynthia Husted
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

2.  Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases.

Authors:  A Biber; D Englert; D Dommasch; K Hempel
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

Review 3.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

4.  Assessing the values of circulating immune complexes in multiple sclerosis patients following immunomodulator or corticosteroid treatment.

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Anca Elena Gogu; Daniel Docu Axelerad
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

5.  Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.

Authors:  P Vanguri; C L Koski; B Silverman; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

6.  Detection of various forms of brain myelin basic protein in vertebrates by electroimmunoblotting.

Authors:  N Kerlero De Rosbo; P R Carnegie; C C Bernard; D S Linthicum
Journal:  Neurochem Res       Date:  1984-10       Impact factor: 3.996

Review 7.  Myelin basic protein and multiple sclerosis.

Authors:  J N Whitaker
Journal:  Ital J Neurol Sci       Date:  1983-06

Review 8.  Immunologic pathogenesis of multiple sclerosis.

Authors:  Min-Fang Guo; Ning Ji; Cun-Gen Ma
Journal:  Neurosci Bull       Date:  2008-12       Impact factor: 5.203

9.  Shape change of blood platelets induced by myelin basic protein.

Authors:  A Laubscher; A Pletscher; C G Honegger; J G Richards; V Colombo
Journal:  Experientia       Date:  1979-08-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.